November 14, 2012

Schizophrenia Commission findings

Schizophrenia affects over 220,000 people in England and an estimated 1 in 6 people will experience some symptoms of psychosis at some stage in their lives.

The Schizophrenia Commission, a panel of 14 leading health and social care figures, have conducted an independent inquiry into the treatment and care of people with Schizophrenia. The Commission heard evidence from 80 experts and people affected by the condition, and received evidence from 2,500 more online. They also received new data from the London School of Economics on the costs associated with Schizophrenia in the UK. 

Topics covered:

• How much does Schizophrenia cost society? Could costs be reduced?
• Are current treatments good enough and what are the alternatives?
• Do patients have access to the best treatments and are we prescribing wisely?
• Are we spending too much on secure care?
• Could we intervene earlier to prevent future illness?
• Does treatment and care of those with schizophrenia need a radical overhaul?

Speakers:

Prof Robin Murray, Professor of Psychiatric Research, Institute of Psychiatry, Kings College London

Prof David Taylor, Director of Pharmacy and Pathology, Kings College London

Dr Alison Brabban, Consultant Clinical Psychologist, Tees, Esk and Wear Valleys NHS Foundation Trust

Prof Martin Knapp, Professor of Social Policy, London School of Economics